| Entry |
|
|---|
| Name |
Pamiparib (USAN/INN) |
|---|
| Formula |
C16H15FN4O
|
|---|
| Exact mass |
298.1230
|
|---|
| Mol weight |
298.31
|
|---|
| Structure |
|
|---|
| Class |
Antineoplastic
DG02942 PARP inhibitor
|
|---|
| Remark |
|
|---|
| Efficacy |
Antineoplastic |
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01X OTHER ANTINEOPLASTIC AGENTS
L01XK Poly (ADP-ribose) polymerase (PARP) inhibitors
L01XK06 Pamiparib
D11426 Pamiparib (USAN/INN)
Drug groups [BR:br08330]
Antineoplastic
DG02942 PARP inhibitor
D11426 Pamiparib
Target-based classification of drugs [BR:br08310]
Enzymes
Transferases (EC2)
Pentosyltransferases
PARP1
D11426 Pamiparib (USAN/INN)
PARP2
D11426 Pamiparib (USAN/INN)
PARP3
D11426 Pamiparib (USAN/INN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 22
1 C8y C 17.0800 -14.2800
2 C8x C 17.0800 -15.6800
3 C8y C 18.2700 -16.3800
4 C8y C 19.5300 -15.6800
5 C8y C 19.5300 -14.2800
6 C8x C 18.2700 -13.5800
7 C8y C 20.8600 -16.1000
8 C8y C 21.6300 -14.9800
9 N4x N 20.8600 -13.8600
10 X F 15.8900 -13.5800
11 C8y C 21.4900 -17.3600
12 C8y C 18.2700 -17.9900
13 N5x N 20.8600 -18.6200
14 N4x N 19.5300 -18.8300
15 O5x O 17.0100 -18.6200
16 C1z C 23.0300 -15.0500
17 N1y N 23.6600 -16.3100
18 C1x C 22.8900 -17.4300
19 C1x C 24.0100 -14.0000
20 C1x C 25.2700 -14.7000
21 C1x C 25.0600 -16.1000
22 C1a C 22.6800 -13.6500
BOND 26
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 4 7 1
8 7 8 2
9 8 9 1
10 5 9 1
11 1 10 1
12 7 11 1
13 11 13 2
14 12 14 1
15 13 14 1
16 12 3 1
17 12 15 2
18 8 16 1
19 16 17 1
20 17 18 1
21 11 18 1
22 16 19 1
23 19 20 1
24 20 21 1
25 17 21 1
26 16 22 1 #Down
|
|---|
